KLK10 exon 3 unmethylated PCR product concentration: a new potential early diagnostic marker in ovarian cancer? - A pilot study

Table 4 Comparison of KLK10 exon 3 unmethylated PCR product concentration (ng/μl) according to patient age

KLK10 exon 3 unmethylated PCR product; ng/μl, mean ± SD	Age group			p-value
KLK10 exon 3 unmethylated PCR product; ng/μl, mean ± SD	16–32 years	33–55 years	> 55 years	p-value
Overall samples (n = 6–27)	0.032 ± 0.029	0.064 ± 0.029	0.090 ± 0.037	0.004^b
Benign patients:
Normal ovary (n = 0–5)	–	0.078 ± 0.034	0.135 ± 0.007	0.078^b
Benign ovary (n = 2–10)	0.060 ± 0.042	0.078 ± 0.034	0.090 ± 0.056	0.728^b
p-value	–	1.00^a	0.380^a
Malignant patients:
Normal ovary (n = 1–3)	0.020 ± −	0.040 ± 0.000	0.070 ± 0.042	0.335^b
Malignant ovary (n = 3–9)	0.017 ± 0.011	0.049 ± 0.010	0.073 ± 0.015	0.000^b
p-value	0.826^a	0.188^a	0.903^a

ISSN: 1757-2215